Literature DB >> 33319768

Chilblain-like eruption in COVID-19 disease: possible pathogenetic role of temperature.

Charlene Wee1, Hong Liang Tey2.   

Abstract

Entities:  

Year:  2020        PMID: 33319768      PMCID: PMC7880645          DOI: 10.1684/ejd.2020.3943

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


× No keyword cloud information.
  5 in total

1.  Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries.

Authors:  Esther E Freeman; Devon E McMahon; Jules B Lipoff; Misha Rosenbach; Carrie Kovarik; Junko Takeshita; Lars E French; Bruce H Thiers; George J Hruza; Lindy P Fox
Journal:  J Am Acad Dermatol       Date:  2020-05-30       Impact factor: 11.527

2.  Coronavirus (COVID-19) infection-induced chilblains: A case report with histopathologic findings.

Authors:  Athanassios Kolivras; Florence Dehavay; Daphné Delplace; Francesco Feoli; Isabelle Meiers; Laurenzo Milone; Catherine Olemans; Ursula Sass; Anne Theunis; Curtis T Thompson; Laura Van De Borne; Bertrand Richert
Journal:  JAAD Case Rep       Date:  2020-04-18

3.  A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection.

Authors:  M El Hachem; A Diociaiuti; C Concato; R Carsetti; C Carnevale; M Ciofi Degli Atti; L Giovannelli; E Latella; O Porzio; S Rossi; A Stracuzzi; S Zaffina; A Onetti Muda; G Zambruno; R Alaggio
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-07-02       Impact factor: 9.228

4.  Comment on "Chilblains-like lesions in children following suspected COVID-19 infection".

Authors:  Beuy Joob; Viroj Wiwanitkit
Journal:  Pediatr Dermatol       Date:  2020-05       Impact factor: 1.997

Review 5.  Cutaneous signs in COVID-19 patients: A review.

Authors:  Uwe Wollina; Ayşe Serap Karadağ; Christopher Rowland-Payne; Anca Chiriac; Torello Lotti
Journal:  Dermatol Ther       Date:  2020-05-29       Impact factor: 2.851

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.